What’s wrong with the way pharma uses e-marketing? At the annual ePharma Summit, a panel of former e-marketers agreed that too many companies think of e-strategies as a separate marketing component rather than as part of a holistic approach.
“Web sites are a natural point of integration,” said moderator Peter Justason (above) of Johnson & [...]

[Read more →]

The topic of healthcare is more discussed on the Internet than Britney Spears—and it’s second only to money. But pharma still hasn’t managed to harness the Web to its full potential. That’s the consensus of a panel of industry experts at this year’s ePharma Summit, taking place today in Philadelphia.
The biggest reason? Fear. It once [...]

[Read more →]

Here are this week’s top news stories, as reported on PharmExec.com:
FDA Puts Kibosh on DTC User Fee Program
In a surprising but not completely unexpected move, FDA announced last week that its DTC user fee program was dead on arrival. Feds cite lack of funding as main reason.
Click to read more>>>
Vytorin Study Causes Media Stir, [...]

[Read more →]

Merck and Schering-Plough have temporarily pulled the plug on their popular ad campaign for Vytorin just days after releasing news that the cholesterol-treatment didn’t reduce arterial plaque in a recent clinical trial. Trial results showed that the billion-dollar drug worked no better than Zocor, a cheaper drug found in Vytorin, the Associated Press reports.
Vytorin, however, [...]

[Read more →]

Here are this week’s top news stories, as reported on PharmExec.com:
More Prescriptions Through Learning: The Doctor’s Choice
New report finds that neither sales reps nor patient requests are the deciding factor when it comes to physician prescribing habits, information is—the more the better.
Click to read>>>
(2)008: Licensed to Sell
Sales representatives will now need a license to [...]

[Read more →]

The board of directors of Shire announced its board-succession plans on Dec. 13. Dr. James H. Cavanaugh will retire as non-executive chairman; Matthew Emmens will succeed him as non-executive chairman. Angus Russell will be appointed chief executive. David Kappler will be appointed as deputy chairman in addition to his existing role as senior independent director.

[...]

[Read more →]

FDA has launched a nationwide search for Director, Center for Drug Evaluation and Research (CDER). The open period for applications continues through Friday, February 1, 2008. The detailed job announcement and instructions for applying are available on the USAJOBS site. See Job Announcement Number FDA-AD-2008-01.

addthis_url = ‘http%3A%2F%2Fblog.pharmexec.com%2F2007%2F12%2F12%2Ffda-launches-search-for-cder-director%2F’;
addthis_title [...]

[Read more →]